Commit To Purchase GenMark Diagnostics At $5, Earn 22.1% Annualized Using Options

Investors eyeing a purchase of GenMark Diagnostics, Inc. (GNMK) shares, but tentative about paying the going market price of $6.21/share, might benefit from considering selling puts among the alternative strategies at their disposal..